Genmab — August 2020
-
Home Infusion of Thyroid Eye Disease Treatment Shows Efficacy of Home Care During Pandemic https://www.pharmacytimes.com/news/home-infusion-of-thyroid-eye-disease-treatment-shows-efficacy-of-home-care-during-pandemic
-
Tak Seacop.
-
Servicemeddelelse: Tjek MARKED ud i topmenuen. Der er nye værktøjer til dig.
-
this will be the same for Ofatumumab; the first B-cell therapy that can be self-administered at home using an autoinjector pen. It is one of the reasons Covid could potentially create a competitive advantage for Ofa (besides the difference in
B cell depletion) -
AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts https://www.fiercebiotech.com/biotech/abbvie-cans-voyager-alzheimer-s-parkinson-s-gene-therapy-pacts
-
-
New trial to compare maintenance therapy with Daratumumab or Lenalidomide https://www.clinicaltrials.gov/ct2/show/NCT04497961?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Duobody+OR+Teprotumumab+OR+Tepezza+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+Teclistamab+OR+Talquetamab+OR+Amivantamab&lupd_s=08%2F04%2F2020&draw=2&rank=2
-
God morgen.
-
Danske Bank: As we await the Q2 20 results and the dust over the AbbVie collaboration settles,
we look for the potential next share price trigger. We think GEN1046 could be
the next pipeline gem and Genmab expects first in human data in H2 20. We keep
our Hold rating and raise our 12M target price to DKK2,300 (DKK2,175).
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind